(Q39917432)

15 September 2017

Growth differentiation factor-15: a new biomarker in cardiovascular disease (English)

1 reference

15 September 2017

0 references

cardiovascular disease

1 reference

Tibor Kempf

1

1 reference

PubMed ID

20024638

15 September 2017

Kai C Wollert

series ordinal

2

1 reference

15 September 2017

1 December 2009

1 reference

15 September 2017

1 reference

15 September 2017

34

1 reference

15 September 2017

8

1 reference

15 September 2017

594-599

1 reference

Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer

15 September 2017

1 reference

https://api.crossref.org/works/10.1007%2FS00059-009-3317-3

Influence of postprandial triglyceride-rich lipoproteins on lipid-mediated gene expression in smooth muscle cells of the human coronary artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-009-3317-3

MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-009-3317-3

Biomarkers in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-009-3317-3

Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-009-3317-3

Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-009-3317-3

The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-009-3317-3

Gene expression pattern in biomechanically stretched cardiomyocytes: evidence for a stretch-specific gene program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-009-3317-3

Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-009-3317-3

The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-009-3317-3

Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-009-3317-3

Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-009-3317-3

Adipocyte culture medium stimulates production of macrophage inhibitory cytokine 1 in MDA-MB-231 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-009-3317-3

Prognostic factors in chronic heart failure. A review of serum biomarkers, metabolic changes, symptoms, and scoring systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-009-3317-3

Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-009-3317-3

Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-009-3317-3

State of the art: using natriuretic peptide levels in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-009-3317-3

Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-009-3317-3

Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-009-3317-3

Universal definition of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-009-3317-3

Redefinition of myocardial infarction--relevance of biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-009-3317-3

Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non ST-Elevation Acute Coronary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-009-3317-3

Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-009-3317-3

GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-009-3317-3

Prognostic Utility of Growth Differentiation Factor-15 in Patients With Chronic Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-009-3317-3

Antiangiogenic Activity of the MDM2 Antagonist Nutlin-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-009-3317-3

Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction

21 January 2018

1 reference

12 December 2020

Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy

1 reference

12 December 2020

Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction

1 reference

12 December 2020

1 reference

12 December 2020

Benchmarks for the assessment of novel cardiovascular biomarkers

1 reference

12 December 2020

10.1007/S00059-009-3317-3

Identifiers

DOI

1 reference

15 September 2017

1 reference

PubMed ID

20024638